Edit this page

From Proteopedia

You do not have permission to do that, for the following reasons:

You do not have permission to edit pages in the Journal namespace.
The action you have requested is limited to users in the group user.

You can view and copy the source of this page:

<StructureSection load='' size='450' side='right' scene='underdevelopment' caption=''>
===  Structural characterization of zinc-bound Zmp1, a zinc-dependent metalloprotease secreted by Clostridium difficile ===
<big>Jeffrey T. Rubino, Manuele Martinelli, Francesca Cantini, Andrea Castagnetti, Rosanna Leuzzi, Lucia Banci and Maria Scarselli</big> <ref>REF</ref>
<hr/>
<b>Molecular Tour</b><br>
''Clostridium difficile'' is a Gram-positive spore-forming anaerobic bacterium which emerged in the last decades as a major cause of antibiotic-associated diarrhea worldwide. Tendency of infection to recur and increase in antibiotic-resistant strains pose new challenges to C. difficile treatment. New-generation small molecules, use of pro-biotics, and fecal microbiota transplantation are all emerging options for prevention and cure of C. difficile infection. Beside the development of new antibiotics, virulence targeting factors and vaccines represent promising strategies, which stimulate the research of new potential antigens and targets for drug design.
C. difficile releases the zinc-dependent metalloprotease Zmp1 in the extracellular medium. Different possible targets have been identified for this protein, including the human fibrinogen, leading to the hypothesis that it could play multiple roles during bacterial host infection. This protein can indeed contribute to several aspects of C. difficile pathogenesis ranging from the damage of host tissues, through hydrolysis of the components of extracellular matrix, to the release and cell wall attachment of virulence factors. 
The structural and dynamic characterization of substrate-free Zmp1 through NMR have revealed that two regions of the protein are affected by local mobility. Such dynamic behavior could play a role in substrate specificity and offers the possibility to investigate and develop specific inhibitors or mutants, that acting on the internal mobility, may impair the activity of C. difficile Zmp1 contributing to prevent the dissemination of this pathogen. 
In the field of vaccine development against Clostridium difficile, the NMR assignment and the solution structure of Zmp1, together with its dynamic characterization, can be useful for mapping residues involved in important functions such as eliciting bactericidal antibodies and it will provide insight into improved vaccine antigen design with higher stability and improved epitope presentation. 

</StructureSection>

<references/>
__NOEDITSECTION__

Templates used on this page:

Return to Main Page.

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.

Retrieved from "http://52.214.119.220/wiki/index.php/Journal:JBIC:33"

Edit this page

From Proteopedia

Views

Personal tools

Navigation

Search

Toolbox